title: Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse.
abstract: It has been demonstrated that the opioid peptide dynorphin plays a role in modulating responses to several psychoactive substances including cocaine. Our laboratory and others have found that mRNA levels of dynorphin in the caudate and putamen are elevated after acute or chronic cocaine exposure in rats. Recently, a 68-base pair (bp) repeat polymorphism within the core promoter region of the human prodynorphin gene has been reported to occur in alleles containing one, two, three, or four copies. This repeat contains a putative AP-1 transcription factor binding site; reporter gene constructs with three or four, but not one or two, copies of the tandem repeats were shown to be associated with increases in transcriptional activation in in vitro cellular assays. We hypothesize that this polymorphism may be associated with individual differences in vulnerability to cocaine dependence or abuse. From an ongoing study of the genetics of addiction, 174 subjects were studied, including individuals with a primary diagnosis (DSM-IV criteria) of cocaine dependence (N = 61) or abuse (N = 22), and controls with no history of any substance dependence or abuse (N = 91). We designed primers for polymerase chain reaction (PCR) to amplify sequences of the promoter region of the prodynorphin gene containing the repeat element. The association of alleles containing three or four repeats with cocaine dependence/abuse was examined. With data stratified by ethnic group, pooled relative risk (RR) with Mantel-Haenszel Chi square was calculated: RR = 0.59 (95% confidence interval 0.37-0.95), chi2 (1) = 4.14, P = 0.042. Our results suggest that this allelic variation at the promoter region of the prodynorphin gene (alleles with three or four repeats), which may result in enhanced transcription of the gene, may contribute to relative protection and decrease individual vulnerability to develop cocaine dependence or abuse.
authors: Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York 10021-6399, USA. chenach@yahoo.com
authors: Andrew C H
authors: AC
authors: Chen
authors: K Steven
authors: KS
authors: LaForge
authors: Ann
authors: A
authors: Ho
authors: Pauline F
authors: PF
authors: McHugh
authors: Scott
authors: S
authors: Kellogg
authors: Kathy
authors: K
authors: Bell
authors: Rosemary P
authors: RP
authors: Schluger
authors: Suzanne M
authors: SM
authors: Leal
authors: Mary Jeanne
authors: MJ
authors: Kreek
mesh_terms: D000483:Alleles; D001483:Base Sequence; D019970:Cocaine-Related Disorders / Q000208:ethnology / Q000235:genetics*; D004247:DNA; D004745:Enkephalins / Q000235:genetics* / Q000502:physiology; D005787:Gene Frequency; D006801:Humans; D008969:Molecular Sequence Data; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D011498:Protein Precursors / Q000235:genetics* / Q000502:physiology; D012091:Repetitive Sequences, Nucleic Acid
chemical_list: D004745:Enkephalins; D011498:Protein Precursors; D004247:DNA; C033660:preproenkephalin